Cargando…

Rationale of combination therapy with antioxidants in medical management of Peyronie’s disease: results of clinical application

Peyronie’s disease (PD) is a connective tissue disorder involving the tunica albuginea of the corpora cavernosa of the penis. We have published several studies describing a “combined therapy” for PD patients, but the present study aims to clearly demonstrate how the association between various antio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paulis, Gianni, Paulis, Andrea, Romano, Gennaro, Barletta, Davide, Fabiani, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530853/ https://www.ncbi.nlm.nih.gov/pubmed/28791261 http://dx.doi.org/10.2147/RRU.S141748

Ejemplares similares

Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review
por: Paulis, Gianni, et al.
Publicado: (2017)

Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study
por: Paulis, Gianni, et al.
Publicado: (2015)

Clinical and epidemiological characteristics of young patients with Peyronie’s disease: a retrospective study
por: Paulis, Gianni, et al.
Publicado: (2015)

Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie’s disease: a retrospective analysis of 309 cases
por: Paulis, Gianni, et al.
Publicado: (2016)

Peyronie’s disease after urethral swab, an unusual complication: a case report
por: Paulis, Gianni, et al.
Publicado: (2015)

Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants
por: Paulis, Gianni, et al.
Publicado: (2022)

Full Regression of Peyronie’s Disease Plaque Following Combined Antioxidant Treatment: A Three-Case Report
por: Paulis, Gianni, et al.
Publicado: (2022)

Disappearance of Plaque Following Treatment with Antioxidants in Peyronie’s Disease Patients—A Report of 3 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

Complete Plaque Regression in Patients with Peyronie’s Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
por: Paulis, Gianni, et al.
Publicado: (2022)

Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases
por: Paulis, G, et al.
Publicado: (2012)

Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy
por: Paulis, Gianni
Publicado: (2018)

Pregnancy and live birth after follicle-stimulating hormone treatment for an infertile couple including a male affected by Sertoli cell-only syndrome
por: Paulis, Gianni, et al.
Publicado: (2017)

Medical Management of Peyronie’s Disease: Review of the Clinical Evidence
por: Teloken, Patrick, et al.
Publicado: (2019)

The Natural History of Peyronie's Disease
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Surgical Management for Peyronie's Disease
por: Segal, Robert L., et al.
Publicado: (2013)

Lichen sclerosus: the role of oxidative stress in the pathogenesis of the disease and its possible transformation into carcinoma
por: Paulis, Gianni, et al.
Publicado: (2019)

AB56. Current medical therapy for peyronie’s disease
por: Moon, Ki Hak
Publicado: (2014)

 Recent advances in managing Peyronie’s disease
por: Kayes, Oliver, et al.
Publicado: (2016)

Recent advances in managing Peyronie’s disease
por: Babu, Asrit, et al.
Publicado: (2020)

Global Perspective on the Management of Peyronie's Disease
por: Moisés da Silva, Gabriel Veber, et al.
Publicado: (2022)

Peyronie’s disease: current therapy
por: Pendleton, Clay M., et al.
Publicado: (2013)

Injectable therapy for Peyronie’s disease
por: Chong, Weiliang, et al.
Publicado: (2016)

Verteporfin as a Medical Treatment in Peyronie’s Disease
por: Mohede, Daan C.J., et al.
Publicado: (2018)

Penile prosthetic surgery for the management of Peyronie’s disease
por: Raheem, Omer A., et al.
Publicado: (2017)

Collagenase clostridium hystolyticum in the management of Peyronie’s disease
por: Ahn, Sun Tae, et al.
Publicado: (2017)

Non-invasive treatment in the management of Peyronie’s disease
por: Randhawa, Karen, et al.
Publicado: (2019)

The use of ultrasonography in the evaluation and management of peyronie’s disease
por: de Jesús, Manuel R., et al.
Publicado: (2020)

Combined Plaque Incision, Buccal Mucosa Grafting, and Additional Tunica Albuginea Plication for Peyronie’s Disease
por: Cormio, Luigi, et al.
Publicado: (2018)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders
por: Paulis, Ludovit, et al.
Publicado: (2015)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Peyronie’s penile plication
por: Cordon, Billy H., et al.
Publicado: (2017)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Portrait of La Peyronie
Publicado: (1939)

Penile traction therapy in Peyronie's disease
por: Greenfield, Jason M
Publicado: (2009)

Contemporary surgical and non-surgical management of Peyronie’s disease
por: Wayne, George F., et al.
Publicado: (2018)

Sonographic patterns of Peyronie's disease in patients with absence of palpable plaques
por: Dell'Atti, Lucio, et al.
Publicado: (2018)

Pharmacological therapy in patients diagnosed with Peyronie's disease
por: Halal, AA, et al.
Publicado: (2012)

Injection therapy for Peyronie’s disease: pearls of wisdom
por: Brant, William O., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jbsd02re0qknchkggaiuudlpgp